Research Keyword: lung transplant

Rasamsonia argillacea brain abscess in a lung transplant recipient: an unexpected infection by an unusual fungal pathogen

A 65-year-old woman who received a lung transplant developed a serious brain infection caused by a rare fungus called Rasamsonia argillacea. Doctors initially struggled to identify this unusual fungus and treated her with multiple antifungal medications, but the infection proved difficult to control because the fungus was resistant to common antifungal drugs. Investigations revealed that the patient had an undiagnosed immune system disorder called chronic granulomatous disease, which made her vulnerable to this rare infection. Despite aggressive treatment including surgery and powerful antifungal medications, the patient’s condition worsened and she eventually passed away.

Read More »

Clinical Significance and Therapeutic Challenges of Scedosporium spp. and Lomentospora prolificans Isolates in a Single-Center Cohort of Lung Transplant Recipients

This study examined rare but serious fungal infections caused by Scedosporium and Lomentospora in lung transplant patients. Of 576 transplant recipients, 11 (2%) developed these infections, which are difficult to treat due to natural resistance to most antifungal medications. The infection type greatly influenced outcomes, with disseminated Lomentospora infections causing 100% mortality despite treatment. The research highlights the urgent need for new diagnostic methods and more effective antifungal drugs to combat these emerging pathogens.

Read More »

Clinical Significance and Therapeutic Challenges of Scedosporium spp. and Lomentospora prolificans Isolates in a Single-Center Cohort of Lung Transplant Recipients

This study examined dangerous fungal infections caused by Scedosporium and Lomentospora species in lung transplant patients at a Spanish hospital. Researchers found these infections were uncommon but very serious, with high death rates especially from the Lomentospora type. Current antifungal drugs often don’t work well against these fungi, highlighting the need for better treatment options.

Read More »

Candida krusei Empyema: A Lung Transplant Case and Systematic Review of the Literature

Candida krusei is a dangerous fungus that can cause fluid buildup around the lungs (empyema), particularly in transplant patients. Unlike common fungal infections that respond to fluconazole, this species is naturally resistant to this drug, making it harder to treat. The fungus forms protective biofilms that shield it from treatment, requiring combination antifungal medications and sometimes surgery to drain the fluid and remove infected tissue for successful recovery.

Read More »

Rasamsonia argillacea brain abscess in a lung transplant recipient: an unexpected infection by an unusual fungal pathogen

A 65-year-old woman who received a lung transplant developed a rare and serious brain infection caused by an unusual fungus called Rasamsonia argillacea. The infection was difficult to diagnose because it looks similar to more common molds under the microscope. During the investigation of this unexpected infection, doctors discovered that the patient had a rare genetic disorder affecting her immune system that had never been diagnosed. This case highlights how unusual infections can reveal hidden immune system problems.

Read More »

Candida krusei Empyema: A Lung Transplant Case and Systematic Review of the Literature

Candida krusei is a dangerous yeast that causes a serious lung infection called empyema, where pus collects around the lungs. This infection is particularly difficult to treat because the yeast is resistant to common antifungal drugs like fluconazole and can form protective biofilms. This systematic review identified only ten cases of this rare infection in the medical literature, showing how uncommon but serious it is, and found that patients need aggressive treatment with multiple antifungal medications combined with surgical drainage to survive.

Read More »
Scroll to Top